Efficacy and Safety of PD-1 Immune Checkpoint Inhibitors in Locally Advanced and Advanced NSCLC Patients With Chronic Viral Infection
2021
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI